Healthcare Realty Trust (NYSE:HR)‘s stock had its “overweight” rating reaffirmed by equities researchers at Morgan Stanley in a report issued on Thursday. They presently have a $34.00 price target on the real estate investment trust’s stock. Morgan Stanley’s price target would suggest a potential upside of 3.16% from the stock’s current price.
HR has been the topic of a number of other research reports. Zacks Investment Research upgraded shares of Healthcare Realty Trust from a “sell” rating to a “hold” rating in a research report on Monday, October 30th. Mizuho restated a “hold” rating and set a $35.00 target price on shares of Healthcare Realty Trust in a research report on Friday, October 27th. BidaskClub upgraded shares of Healthcare Realty Trust from a “sell” rating to a “hold” rating in a research report on Saturday, August 19th. Cantor Fitzgerald reiterated a “buy” rating on shares of Healthcare Realty Trust in a research report on Wednesday, August 23rd. Finally, BMO Capital Markets reiterated a “buy” rating and set a $34.00 price target on shares of Healthcare Realty Trust in a research report on Monday, October 2nd. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and five have assigned a buy rating to the stock. Healthcare Realty Trust presently has an average rating of “Hold” and an average price target of $33.29.
Healthcare Realty Trust (NYSE HR) traded up $0.62 during trading on Thursday, reaching $32.96. 2,412,400 shares of the company’s stock traded hands, compared to its average volume of 736,678. The company has a market cap of $4,038.95, a PE ratio of 20.60, a P/E/G ratio of 5.17 and a beta of 0.32. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.82 and a current ratio of 2.82. Healthcare Realty Trust has a 52-week low of $28.63 and a 52-week high of $36.25.
Healthcare Realty Trust (NYSE:HR) last announced its earnings results on Wednesday, November 1st. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.39 by ($0.01). Healthcare Realty Trust had a return on equity of 6.62% and a net margin of 26.70%. The business had revenue of $106.95 million for the quarter, compared to analyst estimates of $108.97 million. During the same quarter in the previous year, the company earned $0.39 EPS. The business’s revenue for the quarter was up 3.2% on a year-over-year basis. equities analysts forecast that Healthcare Realty Trust will post 1.57 EPS for the current year.
In related news, Director John Knox Singleton bought 3,074 shares of the business’s stock in a transaction on Friday, November 10th. The shares were purchased at an average price of $32.55 per share, for a total transaction of $100,058.70. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP John M. Bryant, Jr. sold 6,638 shares of the firm’s stock in a transaction that occurred on Tuesday, December 12th. The shares were sold at an average price of $32.38, for a total transaction of $214,938.44. Following the completion of the sale, the executive vice president now owns 176,812 shares in the company, valued at approximately $5,725,172.56. The disclosure for this sale can be found here. Company insiders own 1.85% of the company’s stock.
Hedge funds have recently added to or reduced their stakes in the company. Fiduciary Trust Co. bought a new position in shares of Healthcare Realty Trust during the second quarter valued at $113,000. Quantbot Technologies LP bought a new position in shares of Healthcare Realty Trust during the third quarter valued at $130,000. Pacad Investment Ltd. raised its stake in shares of Healthcare Realty Trust by 41.2% during the second quarter. Pacad Investment Ltd. now owns 4,800 shares of the real estate investment trust’s stock valued at $164,000 after acquiring an additional 1,400 shares during the last quarter. PNC Financial Services Group Inc. raised its stake in shares of Healthcare Realty Trust by 1.2% during the second quarter. PNC Financial Services Group Inc. now owns 6,219 shares of the real estate investment trust’s stock valued at $212,000 after acquiring an additional 72 shares during the last quarter. Finally, Neuberger Berman Group LLC raised its stake in shares of Healthcare Realty Trust by 0.7% during the second quarter. Neuberger Berman Group LLC now owns 6,267 shares of the real estate investment trust’s stock valued at $214,000 after acquiring an additional 46 shares during the last quarter. 95.75% of the stock is owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION WARNING: “Healthcare Realty Trust’s (HR) Overweight Rating Reiterated at Morgan Stanley” was originally reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this story on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at https://ledgergazette.com/2017/12/14/healthcare-realty-trusts-hr-overweight-rating-reiterated-at-morgan-stanley.html.
About Healthcare Realty Trust
Healthcare Realty Trust Incorporated is a self-managed and self-administered real estate investment trust. The Company owns, leases, manages, acquires, finances, develops and redevelops real estate properties associated primarily with the delivery of outpatient healthcare services across the United States.
Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.